Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06134882 · ClinicalTrials.gov registry record · NA

OUD Smartphone Services

A NA study of Opioid-Related Disorders and Drug Abuse, sponsored by Western Michigan University.

Active
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT06134882: Active NA study of Opioid-Related Disorders and Drug Abuse, sponsored by Western Michigan University.

NCT06134882 is a NA study of Opioid-Related Disorders and Drug Abuse that is active but no longer recruiting, run by Western Michigan University. The registered enrollment target is 250 participants, below the 342-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06134882, a NA study of Opioid-Related Disorders and Drug Abuse, is active but no longer recruiting, sponsored by Western Michigan University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The purpose of the research is to check whether services and materials made available through a smartphone app are helpful to people who have been diagnosed with opioid use disorder (OUD). Participants are asked to use an app to submit videos of themselves taking salivary drug tests to a secure online system. The app includes reminders, rewards, and activities, as well as access to live support. Study participation lasts one year and includes about 30 minutes each week submitting videos, an hour-long interview to get started, and hour-long interviews once every three months after that over the course of the year.

Primary Outcome

Abstinence from all unprescribed drugs as measured by independent, lab-based salivary toxicology testing (Y/N) collected every 4 weeks throughout the initial 16-week Study Period.

Interventions

  • BEHAVIORAL Contingency management
  • BEHAVIORAL Cognitive-Behavior Therapy Modules
  • BEHAVIORAL Peer Contingency Management (CM) Guide
  • BEHAVIORAL Drug testing
  • BEHAVIORAL Wellness modules

Study Locations (1)

Michigan

  • Western Michigan University - Kalamazoo

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-04-23
Est. Completion 2026-05-31
Phase NA
Western Michigan University

6 total trials

What the registry record for NCT06134882 still lists

NCT06134882 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 342-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (27% lower).

The record links to 2 conditions, with Opioid-Related Disorders appearing as the primary indexed condition, and to 5 interventions - of which Contingency management is the first listed.

NCT06134882 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06134882 about?

NCT06134882 is a clinical study titled "OUD Smartphone Services". The purpose of the research is to check whether services and materials made available through a smartphone app are helpful to people who have been diagnosed with opioid use disorder (OUD). Participants are asked to use an app to submit videos of themselves taking salivary drug tests to a secure onli...

What is the current status of trial NCT06134882?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-04-23. Estimated completion is 2026-05-31.

What conditions does trial NCT06134882 study?

This clinical trial studies the following conditions: Opioid-Related Disorders, Drug Abuse.

What interventions are being tested in trial NCT06134882?

The interventions under investigation include: Contingency management (BEHAVIORAL), Cognitive-Behavior Therapy Modules (BEHAVIORAL), Peer Contingency Management (CM) Guide (BEHAVIORAL), Drug testing (BEHAVIORAL), Wellness modules (BEHAVIORAL).

Who is sponsoring clinical trial NCT06134882?

This trial is sponsored by Western Michigan University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06134882 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06134882's enrollment target sits among peer trials

250 15th of 47 higher than 33 of 47 other Opioid-Related Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06134882, the US trial registry maintained by the National Library of Medicine. NCT06134882 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.